Report: Connecticut taxpayers owed millions in EpiPen overpayments

Local lawmakers traveled to Hartford Friday to demand a full refund after a new report shows taxpayers in Connecticut are owed millions in EpiPen overpayments.
The report shows Mylan overcharged the federal Medicaid program at least $1.27 billion.
Lawmakers also want the Department of Justice to reject a $465 million settlement offer from the company.
According to the report, Mylan falsely labeled EpiPens as a generic drug, allowing the company to pay 'lower rebates' and collect huge profits at the expense of taxpayers.
News 12 has recently updated to a brand new version of our iOS and Android apps.  If you don't have auto updates enabled on your devices, head to the App Store or Google Play Store to update to the latest version.  This will ensure you keep getting up-to-date local news, traffic and weather information.